Evidence map›Paper›PMID 33920220›Full record

ReviewCells2021

Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer.

Zoi Spyropoulou, Angelos Papaspyropoulos, Nefeli Lagopati, Vassilios Myrianthopoulos, Alexandros G Georgakilas, Maria Fousteri, Athanassios Kotsinas, Vassilis G Gorgoulis

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Transcription-Coupled Repair and R-Loop Crosstalk in Genome Stability.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Zoi SpyropoulouBiomedical Sciences Research Center Alexander Fleming, Institute for Fundamental Biomedical Research, 16672 Athens, Greece.
Angelos PapaspyropoulosMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Nefeli LagopatiMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vassilios MyrianthopoulosDepartment of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece.ORCID 0000-0001-8359-9634
Alexandros G GeorgakilasDNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), 15780 Athens, Greece.ORCID 0000-0002-5971-0010
Maria FousteriBiomedical Sciences Research Center Alexander Fleming, Institute for Fundamental Biomedical Research, 16672 Athens, Greece.ORCID 0000-0003-1729-5899
Athanassios KotsinasMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vassilis G GorgoulisMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-9001-4112
National and Kapodistrian University of Athens · GRAlexander Fleming Biomedical Sciences Research Center · GRNational Technical University of Athens · GR

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
European Research Council 309612General Secretariat for Research and Technology Flagship Initiative to address SARS-CoV-2 (2020ΣΕ01300001)Hellenic Foundation for Research and Innovation grants no. 775 and 3782Horizon 2020 Marie Sklodowska-Curie 722729National and Kapodistrian University of Athens SARG grant 70/3/8916NIGMS NIH HHS R01 GM129325Pappas donationWelfare Foundation for Social & Cultural Sciences KIKPE
6 · The paper itself

Abstract

Cockayne syndrome (CS) is a DNA repair syndrome characterized by a broad spectrum of clinical manifestations such as neurodegeneration, premature aging, developmental impairment, photosensitivity and other symptoms. Mutations in Cockayne syndrome protein B (CSB) are present in the vast majority of CS patients and in other DNA repair-related pathologies. In the literature, the role of CSB in different DNA repair pathways has been highlighted, however, new CSB functions have been identified in DNA transcription, mitochondrial biology, telomere maintenance and p53 regulation. Herein, we present an overview of identified structural elements and processes that impact on CSB activity and its post-translational modifications, known to balance the different roles of the protein not only during normal conditions but most importantly in stress situations. Moreover, since CSB has been found to be overexpressed in a number of different tumors, its role in cancer is presented and possible therapeutic targeting is discussed.

Indexed as

AnimalsCockayne SyndromeDNA DamageDNA HelicasesDNA RepairDNA Repair EnzymesGene Expression Regulation, NeoplasticHumansModels, MolecularMutationNeoplasmsPoly-ADP-Ribose Binding ProteinsProtein ConformationProtein Processing, Post-TranslationalDNA HelicasesDNA Repair EnzymesERCC6 protein, humanPoly-ADP-Ribose Binding ProteinscancerCockayne syndromeCockayne syndrome pathologiesCockayne syndrome protein BCSBERCC6

Identifiers

PMID33920220
PMCPMC8068816
OpenAlexW3152909158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.